33 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Oct 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
1
Ending by 2030
Oct 2027
Next term end
14
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2036 · High confidence
Also notable
Ends Jun 2036 · High confidence
Also notable
Ends Jun 2033 · High confidence
Taxane Particles and Their Use
US 9,814,685
The most cited patent in this portfolio, cited by 61 later US patents, top 5% of utility patents granted in 2017 in our data. Protection runs to 2036.
Methods for Solid Tumor Treatment
US 11,458,133
Cited by 10 later US patents, top 25% of utility patents granted in 2022 in our data. Protection runs to 2036. A terminal disclaimer caps this term to an earlier patent's.
Equipment Assembly for and Method of Processing Particles
US 9,233,348
Cited by 33 later US patents, top 25% of utility patents granted in 2016 in our data, and renewed at every maintenance window due so far. Protection runs to 2033. A terminal disclaimer caps this term to an earlier patent's.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 4 fees due Feb 27 to 28, 2027 · next Feb 27
- 1 fee due Mar 3, 2027The maintenance fee for Methods for Treating Lung Disorders (US 10,398,646) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
- 2 fees due Jun 17, 2027
- 1 fee due Jul 12, 2027The maintenance fee for Equipment Assembly for and Method of Processing Particles (US 9,233,348) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
- 2 fees due Sep 5 to 19, 2027 · next Sep 5
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 14 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Taxane Particles and Their Use | 6 in force | to Jun 2036 |
| Methods for Solid Tumor Treatment | 6 in force | to Jun 2036 |
| Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer | 4 in force | to Dec 2038 |
| Treatment of Epithelial Cysts by Intracystic Injection of Antineoplastic Particles | 3 in force | to Jul 2038 |
| Methods for Treating Lung Disorders | 3 in force | to Jun 2038 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,744,923 | Method for Precipitation of Small Medicament Particles into Use Containers In force · High confidence | In force | High confidence | |
| US 8,778,181 | Equipment Assembly for and Method of Processing Particles In force · High confidence | In force | High confidence | |
| US 9,233,348 | Equipment Assembly for and Method of Processing Particles In force · High confidence | In force | High confidence | |
| US 9,925,512 | Equipment Assembly for and Method of Processing Particles In force · High confidence | In force | High confidence | |
| US 9,814,685 | Taxane Particles and Their Use In force · High confidence | In force | High confidence | |
| US 9,918,957 | Methods for Making Compound Particles In force · High confidence | In force | High confidence | |
| US 10,391,090 | Methods for Solid Tumor Treatment In force · High confidence | In force | High confidence | |
| US 10,507,195 | Taxane Particles and Their Use In force · High confidence | In force | High confidence | |
| US 10,729,673 | Taxane Particles and Their Use In force · High confidence | In force | High confidence | |
| US 10,874,660 | Methods for Solid Tumor Treatment In force · High confidence | In force | High confidence |
Also on record, not counted in the 33: 1 patent ended · 5 applications pending · 20 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.